SILO insider transaction filings
Silo Pharma, Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-16. Screen SILO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-16 | 4 | Weisblum Eric — Chief Executive Officer, Director | Purchase (P): 2,500 @ $0.41 · Purchase (P): 2,500 @ $0.42 | EDGAR |
| 2025-11-21 | 4 | Weisblum Eric — Chief Executive Officer, Director | Purchase (P): 1,000 @ $0.37 · Purchase (P): 1,000 @ $0.36 | EDGAR |
| 2025-11-20 | 4 | Weisblum Eric — Chief Executive Officer, Director | Purchase (P): 7,500 @ $0.40 · Purchase (P): 4,500 @ $0.41 | EDGAR |
| 2025-05-28 | 4 | Weisblum Eric — Chief Executive Officer, Director | Purchase (P): 10,000 @ $0.43 | EDGAR |
| 2025-05-27 | 4 | Linsley Wayne — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Munoz Kevin — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Ryweck Daniel E. — Chief Financial Officer | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Weisblum Eric — Chief Executive Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Pavell Jeff — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Silo Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-29 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-10-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SILO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →